Hannah Wolford

1.2k total citations · 1 hit paper
23 papers, 740 citations indexed

About

Hannah Wolford is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Hannah Wolford has authored 23 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Applied Microbiology and Biotechnology, 10 papers in Epidemiology and 8 papers in Molecular Medicine. Recurrent topics in Hannah Wolford's work include Antibiotic Use and Resistance (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Hannah Wolford is often cited by papers focused on Antibiotic Use and Resistance (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Hannah Wolford collaborates with scholars based in United States and Uganda. Hannah Wolford's co-authors include James Baggs, Sujan Reddy, Prabasaj Paul, Kelly M Hatfield, John A. Jernigan, Babatunde Olubajo, Richard E. Nelson, Natalie McCarthy, Anthony E. Fiore and Alex Kallen and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Hannah Wolford

21 papers receiving 725 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017

2020 384 citations John A. Jernigan, Kelly M Hatfield et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannah Wolford United States	8	283	212	160	148	116	23	740
Babatunde Olubajo United States	10	245 0.9×	150 0.7×	161 1.0×	143 1.0×	133 1.1×	20	750
Houssein Gbaguidi‐Haore France	17	278 1.0×	139 0.7×	187 1.2×	151 1.0×	130 1.1×	53	715
Myrto Christofidou Greece	18	411 1.5×	210 1.0×	221 1.4×	342 2.3×	119 1.0×	40	836
Iain J. Abbott Australia	16	434 1.5×	119 0.6×	130 0.8×	308 2.1×	220 1.9×	41	995
Mark Supino United States	6	163 0.6×	234 1.1×	90 0.6×	180 1.2×	81 0.7×	11	660
Eimear Brannigan United Kingdom	13	235 0.8×	187 0.9×	143 0.9×	117 0.8×	102 0.9×	24	536
Yusuf Yakupoğulları Türkiye	14	301 1.1×	86 0.4×	153 1.0×	181 1.2×	109 0.9×	59	678
Yonghong Xiao China	16	367 1.3×	243 1.1×	98 0.6×	245 1.7×	219 1.9×	56	872
Angella Charnot‐Katsikas United States	15	428 1.5×	116 0.5×	242 1.5×	228 1.5×	168 1.4×	30	940
Hyuck Lee South Korea	18	249 0.9×	109 0.5×	233 1.5×	420 2.8×	229 2.0×	44	941

Countries citing papers authored by Hannah Wolford

Since Specialization

Citations

This map shows the geographic impact of Hannah Wolford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Wolford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Wolford more than expected).

Fields of papers citing papers by Hannah Wolford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Wolford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Wolford. The network helps show where Hannah Wolford may publish in the future.

Co-authorship network of co-authors of Hannah Wolford

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Wolford. A scholar is included among the top collaborators of Hannah Wolford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Wolford. Hannah Wolford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolford, Hannah, Natalie McCarthy, James Baggs, et al.. (2025). Antimicrobial-Resistant Infections in Hospitalized Patients. JAMA Network Open. 8(3). e2462059–e2462059. 6 indexed citations

Lutgring, Joseph D., Kathryn A. Haass, Natalie McCarthy, et al.. (2025). The Impact of a Nationwide Blood Culture Bottle Shortage in 2024 on Healthcare Facilities in the United States. Clinical Infectious Diseases.

McCarthy, Natalie, James Baggs, Hannah Wolford, et al.. (2024). Length of antibiotic therapy among adults hospitalized with uncomplicated community-acquired pneumonia, 2013–2020. Infection Control and Hospital Epidemiology. 45(6). 726–732. 2 indexed citations

Wolford, Hannah, James Baggs, Sujan Reddy, et al.. (2023). Antibiotic Use Among Hospitalized Patients With COVID-19 in the United States, March 2020–June 2022. Open Forum Infectious Diseases. 10(11). ofad503–ofad503. 6 indexed citations

Baggs, James, Natalie McCarthy, Sujan Reddy, & Hannah Wolford. (2023). 2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations

Benedict, Kaitlin, James Baggs, Hannah Wolford, Brendan R. Jackson, & Jeremy A.W. Gold. (2023). Hospitalizations for Unspecified Mycoses in a Large Administrative Data Set and Implications for Fungal Disease Burden Estimates, United States, 2019–2021. Open Forum Infectious Diseases. 10(3). ofad100–ofad100. 4 indexed citations

Baggs, James, et al.. (2023). 2455. National Trends in the Rates of Drug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-2021. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Lyman, Meghan, Brendan R. Jackson, Shawn R. Lockhart, et al.. (2023). Fluconazole resistance in non-albicans Candida species in the United States, 2012-2021. SHILAP Revista de lepidopterología. 3(S2). s29–s30. 2 indexed citations

Wolford, Hannah, Natalie McCarthy, James Baggs, & Sujan Reddy. (2023). 1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations

10.

Kazakova, Sophia V., James Baggs, Hussain Yusuf, et al.. (2022). Declines in the utilization of hospital‐based care during COVID‐19 pandemic. Journal of Hospital Medicine. 17(12). 984–989. 16 indexed citations

11.

Ham, D. Cal, Lucy Fike, Hannah Wolford, et al.. (2022). Trimethoprim-sulfamethoxazole resistance patterns among Staphylococcus aureus in the United States, 2012–2018. Infection Control and Hospital Epidemiology. 44(5). 794–797. 7 indexed citations

12.

Baggs, James, Natalie McCarthy, Hannah Wolford, et al.. (2022). Antibiotic-Resistant Infections Among Inpatients with Coronavirus Disease 2019 (COVID-19) in US Hospitals. Clinical Infectious Diseases. 75(Supplement_2). S294–S297. 11 indexed citations

13.

Hatfield, Kelly M, James Baggs, Hannah Wolford, et al.. (2022). Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020–November 2021. Clinical Infectious Diseases. 75(Supplement_2). S147–S154. 7 indexed citations

14.

Baggs, James, Hannah Wolford, Melinda M. Neuhauser, et al.. (2021). Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic. Open Forum Infectious Diseases. 8(6). 44 indexed citations

15.

Johansson, Michael A., Hannah Wolford, Prabasaj Paul, et al.. (2021). Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing. BMC Medicine. 19(1). 94–94. 32 indexed citations

16.

Jernigan, John A., Kelly M Hatfield, Hannah Wolford, et al.. (2020). Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017. New England Journal of Medicine. 382(14). 1309–1319. 384 indexed citations breakdown →

17.

Kazakova, Sophia V., Natalie McCarthy, James Baggs, et al.. (2020). 121. Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012–2017. Open Forum Infectious Diseases. 7(Supplement_1). S74–S74. 1 indexed citations

18.

Nelson, Richard E., Kelly M Hatfield, Hannah Wolford, et al.. (2020). National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States. Clinical Infectious Diseases. 72(Supplement_1). S17–S26. 162 indexed citations

19.

Bower, Chris, Hannah Wolford, Rachel B. Slayton, et al.. (2019). Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network Analysis. Clinical Infectious Diseases. 70(1). 75–81. 7 indexed citations

20.

Wolford, Hannah, Kelly M Hatfield, Prabasaj Paul, Sarah H. Yi, & Rachel B. Slayton. (2018). The projected burden of complex surgical site infections following hip and knee arthroplasties in adults in the United States, 2020 through 2030. Infection Control and Hospital Epidemiology. 39(10). 1189–1195. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact